First new treatment for Alzheimer’s disease approved in nearly two decades offers hope for people living with dementia
First new treatment for Alzheimer’s disease approved in nearly two decades offers hope for people living with dementia Alzheimer Society of Canada calls for more investment in dementia research TORONTO, June 7, 2021 /CNW/ – The Alzheimer Society of Canada is hopeful about the U.S. Food and Drug Administration’s (FDA) approval of aducanumab, a new … Continue reading First new treatment for Alzheimer’s disease approved in nearly two decades offers hope for people living with dementia
Celltrion Healthcare launches Remsima™ SC, the world’s first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis
Celltrion Healthcare launches Remsima™ SC, the world’s first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis Remsima™ SC offers an innovative treatment option for patients living with chronic inflammatory conditions in Canada Remsima™ SC is supported by the CELLTRION CONNECT™ Patient Support Program Celltrion Healthcare Canada Limited aims to … Continue reading Celltrion Healthcare launches Remsima™ SC, the world’s first subcutaneous formulation of infliximab in Canada, for the treatment of people with rheumatoid arthritis
Health Canada Approves AbbVie’s RINVOQ® (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
Health Canada Approves AbbVie’s RINVOQ® (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Approval supported by efficacy and safety data of two pivotal Phase 3 studies in which RINVOQ demonstrated improved joint outcomes, physical function and skin symptoms, with a greater proportion of patients achieving minimal disease activity versus placebo* 1,2 Significantly more patients … Continue reading Health Canada Approves AbbVie’s RINVOQ® (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
On World Oceans Day, Oceana Canada calls on Feds to Put Wild Fish First in Developing a Blue Economy Strategy
On World Oceans Day, Oceana Canada calls on Feds to Put Wild Fish First in Developing a Blue Economy Strategy Only ¼ of our Fisheries are Healthy; 97% of Canadians Want the Government to Rebuild Them TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — On the eve of World Oceans Day, new polling1 released today from Oceana … Continue reading On World Oceans Day, Oceana Canada calls on Feds to Put Wild Fish First in Developing a Blue Economy Strategy
EOSERA Informs on Benefits of Nasal Rinsing with New Product: NOSE WELL™
EOSERA Informs on Benefits of Nasal Rinsing with New Product: NOSE WELL™ Backed by science, EOSERA educates on the advantages of nasal rinsing. EOSERA’s newest product, NOSE WELL™, is a gravity-fed device used to rinse out the sinus cavities, treating symptoms like congestion. Fort Worth, TX, June 8th, 2021 – Studies show that rinsing the nasal … Continue reading EOSERA Informs on Benefits of Nasal Rinsing with New Product: NOSE WELL™
